Welcome to our dedicated page for ANTM news (Ticker: ANTM), a resource for investors and traders seeking the latest updates and insights on ANTM stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ANTM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ANTM's position in the market.
Anthem, Inc. (NYSE: ANTM) reported strong third-quarter results with GAAP net income of $6.13 per share, an increase in operating revenue by 16.0% to $35.5 billion, and a significant increase in medical enrollment by 2.4 million members year-over-year. The company raised its full-year adjusted net income outlook from greater than $25.50 to greater than $25.85 per share. A dividend of $1.13 per share was declared for Q4 2021. Operating cash flow reached $2.5 billion, a substantial increase compared to the prior year.
Anthem, Inc. (NYSE: ANTM) is set to announce its third quarter 2021 financial results on October 20, 2021, at 6:00 a.m. EDT. A conference call will follow at 8:30 a.m. EDT, where management will discuss the results and future outlook. Interested parties can join the call using specific dial-in numbers provided, with a replay available until November 19, 2021. Anthem serves over 117 million people and aims to be an innovative partner in health benefits. For more details, visit www.antheminc.com.
Anthem, Inc. (NYSE: ANTM) has announced that over 72% of Medicare Advantage members enrolled in its affiliated health plans for 2022 will be in plans rated four stars or higher. This increase is attributed to Anthem's ongoing investments in healthcare quality and access. The company aims to improve consumer experiences through collaborations with providers and digital service strategies. Notably, two Anthem-affiliated plans in Florida received five-star ratings for 2022, recognizing their consistent excellence amidst healthcare challenges, including those posed by COVID-19.
Anthem, Inc. (NYSE: ANTM) has announced significant senior leadership changes aimed at positioning the company for future growth. Effective October 5, Pete Haytaian will lead the diversified business group and IngenioRx, while Morgan Kendrick will take charge of Anthem’s commercial business. Rajeev Ronanki has been appointed as President of Digital Platforms, focusing on enhancing the company's digital capabilities. These changes reflect Anthem's commitment to deliver innovative health solutions and adapt to evolving consumer needs.
Anthem, Inc. (NYSE: ANTM) will present at the Cantor Global Healthcare Conference on September 27, 2021, at 11:20 a.m. EDT. Interested parties can access the live webcast through Anthem's website and are encouraged to log in 15 minutes early for technical preparation. A replay of the webcast will be available for two weeks post-event. Anthem serves over 117 million individuals, with over 44 million in its health plans, focusing on improving lives and simplifying healthcare.
Anthem, Inc. (NYSE: ANTM) will present at the 19th Annual Morgan Stanley Global Healthcare Conference on September 9, 2021, at 3:00 p.m. EDT, followed by a presentation at the Wells Fargo Virtual Healthcare Conference on September 10, 2021, at 12:00 p.m. EDT. Interested parties can access webcasts of the presentations on Anthem’s website. Webcast replays will be available for two weeks post-event. Anthem serves over 117 million people, committing to make healthcare simpler and more accessible.
Target Corporation (NYSE: TGT) announced the appointment of David P. Abney and Gail K. Boudreaux to its board of directors. Abney, former CEO of UPS, brings over 40 years of experience in logistics and corporate leadership, while Boudreaux, CEO of Anthem, has extensive expertise in healthcare management. Abney's appointment is effective immediately, and Boudreaux's will take effect on September 23, 2021. This strategic move aims to enhance Target's board with experienced professionals who have led complex corporate strategies in rapidly changing environments.
The Board of Directors of Anthem (NYSE: ANTM) announced the appointment of Susan Dodson DeVore to its board. With extensive experience in healthcare and finance, Ms. DeVore previously served as CEO of Premier, Inc., where she led its successful IPO and fostered ethical and innovative practices. Her background includes over two decades in finance and healthcare consulting at Ernst & Young. Anthem's Chair, Elizabeth Tallett, expressed confidence that Ms. DeVore's expertise will enhance the Board's insights as the company focuses on improving health outcomes.
FAQ
What is the market cap of ANTM (ANTM)?
